Bernie Sanders of Vermont, chair of the Health, Education, Labor and Pensions committee, complaining that these treatments could bankrupt Medicare
It has a weight loss effect similar to Wegovy
Weight loss: the slowest but most visible outcome Weight loss is the outcome everyone focuses on, but it is the slowest to manifest in meaningful amounts
Phentermine is one of the most commonly discussed combinations
In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial
This is a pre-specified nested study of the IIH:Pressure trial that aimed to determine the effects of exenatide on cognition in a cohort of IIH patients with raised ICP